Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Manu Ohri currently holds 15,001 shares of GT Biopharma, Inc. (GTBP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Manu Ohri has been a net buyer of GTBP stock. They have purchased $25.0K and sold $0 worth of shares.
Manu Ohri's most recent insider trade was on Jan 15, 2026, when they sold 5,000 shares at $0.00 per share.
Manu Ohri serves as Executive at GT Biopharma, Inc. (GTBP). They have executed 9 insider transactions totaling $25.0K over their tenure at the company.
Manu Ohri holds the position of Executive at GT Biopharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Manu Ohri has shown a buying trading pattern, with $25.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Manu Ohri was on Aug 11, 2023, when they purchased $58.0K worth of GTBP shares. This transaction involved 200,000 shares at $0.29 per share.
Manu Ohri currently owns 15,001 shares of GT Biopharma, Inc. (GTBP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Manu Ohri's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Manu Ohri has 9 Form 4 filings on record as an insider at GT Biopharma, Inc..
Set alerts for Manu Ohri and 40,000+ other insiders.